Clinical lymphadenopathy (cN+) from prostate cancer (PCa) identified on imaging remains a
contraindication to radical prostatectomy (RP) according to guidelines. We tested the …

Background: In high-risk prostate cancer (HR-PCA), it is important to consider the factors
associated with extensive lymph node invasion (LNI) before planning treatment methods …

Background: The therapeutic role of pelvic lymph-node dissection (PLND) for prostate
cancer (PCa) is still unclear. The aim of this study was to assess the impact of the number of …

PURPOSE: Subclassification of nodal stage may have prognostic value in men with lymph
node metastasis at radical prostatectomy. We explored the role of extranodal extension, size …

Historically, patients with high risk prostate cancer were considered poor candidates for
radical prostatectomy (RP) due to the likelihood of positive pelvic lymph nodes and …

Background The role of extended pelvic lymph node dissection (EPLND) in the surgical
management of prostate cancer (PCa) patients remains controversial, mainly because of a …

CONTEXT: Pelvic lymph node dissection (PLND) is considered the most reliable procedure
for the detection of lymph node metastases in prostate cancer (PCa); however, the …

Introduction: The only definite way to determine lymph node metastasis, an unfavorable
prognostic factor in prostate cancer is lymphadenectomy. Due to increased morbidity and …

Background Salvage lymph node dissection (SLND) represents a possible treatment option
for prostate cancer patients affected by nodal recurrence after local treatment. However …

OBJECTIVES: To characterize lymph node metastasis of prostate cancer (PCa) and identify
the parameters associated with patient outcome. The incidence of clinically localized PCa …